Elevated expression of ACE2 in tumor-adjacent normal tissues of cancer patients

Affiliations

Comment

Tom Winkler et al. Int J Cancer. 2020.

. 2020 Dec 1;147(11):3264-3266.

doi: 10.1002/ijc.33145. Epub 2020 Jul 17.

¹ Department of Human Molecular Genetics and Biochemistry, School of Medicine, Tel Aviv University, Tel Aviv, Israel.

No abstract available

Keywords: ACE2; COVID-19; NAT; SARS-CoV-2.

Comment on

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Liang W, et al. Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14. Lancet Oncol. 2020. PMID: 32066541 Free PMC article. No abstract available.

1. Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol. 2020;21:621-630.
1. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335-337.
1. Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for cancer patients. Lancet Oncol. 2020;21:180.
1. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271-280.
1. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-273.